Welcome to Paid Research Studies


Browse Locations ... United States» ... New Hampshire» ... Concord





  • Conditions:   Adenosquamous Lung Carcinoma;   Large Cell Lung Carcinoma;   Lung Adenocarcinoma;   Stage IB Non-Small Cell Lung Carcinoma;   Stage IIA Non-Small Cell Lung Carcinoma;   Stage IIB Non-Small Cell Lung Carcinoma;   Stage IIIA Non-Small Cell Lung Cancer
    Interventions:   Other: Cytology Specimen Collection Procedure;   Other: Laboratory Biomarker Analysis
    Sponsor:   National Cancer Institute (NCI)
    Recruiting - verified September 2015

  • Conditions:   Glioblastoma;   Gliosarcoma
    Interventions:   Other: Laboratory Biomarker Analysis;   Other: Placebo;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration;   Drug: Temozolomide;   Drug: Veliparib
    Sponsors:   National Cancer Institute (NCI);   AbbVie
    Recruiting - verified December 2015

  • Conditions:   Stage IB Breast Cancer;   Stage II Breast Cancer
    Interventions:   Radiation: regional nodal XRT;   Radiation: chestwall XRT;   Radiation: WBI
    Sponsors:   NSABP Foundation Inc;   National Cancer Institute (NCI);   Radiation Therapy Oncology Group
    Recruiting - verified February 2016

  • Conditions:   Stage II Diffuse Large B-Cell Lymphoma;   Stage III Diffuse Large B-Cell Lymphoma;   Stage IV Diffuse Large B-Cell Lymphoma
    Interventions:   Drug: Cyclophosphamide;   Drug: Doxorubicin Hydrochloride;   Other: Laboratory Biomarker Analysis;   Drug: Lenalidomide;   Drug: Prednisone;   Biological: Rituximab;   Drug: Vincristine Sulfate
    Sponsor:   National Cancer Institute (NCI)
    Recruiting - verified September 2015

  • Condition:   Breast Cancer
    Interventions:   Drug: Trastuzumab;   Drug: Paclitaxel;   Drug: Trastuzumab emtansine
    Sponsor:   Dana-Farber Cancer Institute
    Recruiting - verified February 2016

  • Conditions:   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIB Non-Small Cell Lung Cancer
    Interventions:   Radiation: 3-Dimensional Conformal Radiation Therapy;   Drug: Carboplatin;   Drug: Cisplatin;   Drug: Crizotinib;   Drug: Erlotinib Hydrochloride;   Drug: Etoposide;   Radiation: Intensity-Modulated Radiation Therapy;   Other: Laboratory Biomarker Analysis;   Drug: Paclitaxel
    Sponsor:   National Cancer Institute (NCI)
    Recruiting - verified November 2015

  • Condition:   Breast Cancer
    Interventions:   Drug: anastrozole;   Drug: everolimus;   Drug: exemestane;   Drug: goserelin acetate;   Drug: letrozole;   Drug: leuprolide acetate;   Drug: tamoxifen citrate;   Other: placebo
    Sponsors:   Southwest Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified January 2016

  • Condition:   Multiple Myeloma
    Interventions:   Drug: Lenalidomide;   Drug: Bortezomib;   Drug: Dexamethasone;   Procedure: Autologous Stem Cell Transplant
    Sponsors:   Paul G. Richardson, MD;   Celgene Corporation;   Millennium Pharmaceuticals, Inc.;   Massachusetts General Hospital;   Cape Cod Healthcare;   Beth Israel Deaconess Medical Center;   Emory University;   University of Michigan;   Fox Chase Cancer Center;   Memorial Sloan Kettering Cancer Center;   Fred Hutchinson Cancer Research Center;   Barbara Ann Karmanos Cancer Institute;   Duke University;   University of California, San Francisco;   University of Chicago;   M.D. Anderson Cancer Center;   UNC Lineberger Comprehensive Cancer Center;   Roswell Park Cancer Institute;   Stanford University;   University of Mississippi Medical Center;   Icahn School of Medicine at Mount Sinai;   Wake Forest Baptist Health;   University of Arizona;   OHSU Knight Cancer Institute;   Eastern Maine Medical Center;   University of California, San Diego;   University of Alabama at Birmingham;   University of Pittsburgh;   Ochsner Health System;   University of Texas Southwestern Medical Center;   State University of New York - Downstate Medical Center;   Newton-Wellesley Hospital;   Baylor College of Medicine;   Beckman Research Institute;   University of Florida;   North Shore Long Island Jewish Health System;   H. Lee Moffitt Cancer Center and Research Institute;   Vanderbilt University;   Ohio State University;   Huntsman Cancer Institute;   Columbia University
    Recruiting - verified January 2016